David Schenkein Location
Boston, United States
David Schenkein Work
- 2023–nowBoard Member @ Regeneron
- 2022–nowBoard Member @ Agios Pharmaceuticals
- 2019–nowGeneral Partner @ GV
- 2015–nowBoard Member @ Denali Therapeutics
See more
- 2009–nowClinical Professor of Medicine @ Tufts Medical Center
- 2019–2022Chairperson of the Board @ Agios Pharmaceuticals
- 2009–2019CEO @ Agios Pharmaceuticals
- 2006–2009Senior Vice President, Clinical Hematology/Oncology @ Genentech
- 2001–2006Senior Vice President, Clinical Research @ Millennium Pharmaceuticals
David Schenkein Investing
General Partner at GV
- Stages
- Series A
- Sectors
- Health tech
- Cheque size
- €230k–€46M
- Freshness
- Verified 1mo ago
David Schenkein Summary
David Schenkein, based in Boston, United States, is a General Partner at GV (Google Ventures). David Schenkein invests in Health tech at Series A, writing €230k–€46M cheques. David Schenkein brings experience from Regeneron, Agios Pharmaceuticals, GV and Denali Therapeutics. David Schenkein's verified email and contact details are available on Mintround.
How to cold email David Schenkein
David Schenkein, GV (Google Ventures) in Boston, United States, backs Health tech companies at Series A, writing €230k–€46M cheques. Here's how to get a reply when you cold email David:
- Subject line: name your company and one metric that matters to Health tech, not “quick chat”.
- First line: your strongest traction, the real numbers, not adjectives.
- One ask: a 20-minute call with a date range. Keep it under 150 words.
- Send it to David's verified address below. No warm intro required.
Every contact is a verified, deliverable email. How Mintround verifies contacts.
Are you David Schenkein? Request removal of this listing.